Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$73.71 - $87.86 $742,849 - $885,453
-10,078 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$77.92 - $102.4 $785,277 - $1.03 Million
10,078 New
10,078 $908,000
Q3 2018

Nov 14, 2018

SELL
$71.81 - $90.15 $351,869 - $441,735
-4,900 Closed
0 $0
Q2 2018

Aug 10, 2018

BUY
$48.54 - $85.31 $237,846 - $418,019
4,900 New
4,900 $376,000

Others Institutions Holding RARE

About Ultragenyx Pharmaceutical Inc.


  • Ticker RARE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,036,896
  • Market Cap $3.14B
  • Description
  • Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...
More about RARE
Track This Portfolio

Track Quantitative Investment Management, LLC Portfolio

Follow Quantitative Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantitative Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quantitative Investment Management, LLC with notifications on news.